Chen Guo, China Securities: The 2025 policy will focus on expanding domestic demand and AI+ in all directions, and the Central Economic Work Conference will be held in Beijing from December 11th to 12th. Chen Guo, chief strategy officer of China Securities, said that the meeting had seven highlights, including clarifying the growth target and fiscal and monetary policy measures, expanding domestic demand in all directions as the top priority of the policy, focusing on "AI+" in science and technology, focusing on implementation of reform measures, paying attention to coping with external shocks in opening up, strengthening the expression of real estate policies, and increasing efforts to improve people's livelihood. Chen Guo said that further RRR cuts and interest rate cuts from the end of 2024 to 2025 are worth looking forward to, and the easing of the liquidity environment has become a market consensus. However, this does not mean that liquidity is rampant, because the growth of money supply in the scale of social financing still continues the requirement of matching the expected target of the overall price level of economic growth. Chen Guo believes that the 2025 policy will focus on expanding domestic demand and AI+ in an all-round way, and the strength and direction of the policy are in line with expectations. With the support of policy expectations and liquidity, it is expected that the market will continue to show the characteristics of volatility. From the perspective of investment strategy, Chen Guo suggested focusing on non-bank finance, real estate chain, consumer electronics, machinery, construction, building materials, steel, social services, catering chain and other sectors. In terms of theme, it is suggested to pay attention to investment opportunities such as "duality" and "two innovations", supply-side optimization, new quality productivity, market value management of state-owned enterprises and CSI A500 index.Clown won the TGA Best Indie Game Award.
Zhendong Pharmaceutical has set up a new health management service company. The enterprise search APP shows that recently, Shanxi Zhendong Health Management Service Co., Ltd. was established, with Zhao Jin as the legal representative and a registered capital of 10 million yuan. Its business scope includes: remote health management services; Health consulting services (excluding medical services), etc. Enterprise investigation shows that the company is wholly owned by Zhendong Pharmaceutical.Defender said that Li Tie had not decided whether to appeal, and Li Tie's defender was interviewed by CCTV reporters outside the court. Regarding the first-instance judgment that Li Tie was sentenced to 20 years, the defender said that Li Tie had not decided whether to appeal, and he would negotiate with Li Tie again. Regarding the state of Li Tie's trial today, the defender's answer is: calm, peaceful and stable. (Tiantian Sports)District 9 of Beijing issued a gale warning. At present, Huairou, Yanqing, Changping, Haidian, Mentougou, Fangshan, Chaoyang, Pinggu and Shijingshan have issued a blue gale warning signal. Today, the wind-cold effect is obvious, and the body feels cold. We should pay attention to wind and cold protection, and stay away from temporary structures such as billboards and tall trees, and do a good job in outdoor aerial work.
ST Mo Long and other materials companies have set up sales business of renewable resources. The enterprise search APP shows that recently, Shandong Cangyuan Materials Co., Ltd. was established, with Liu Shuai as the legal representative and a registered capital of 5 million yuan. Its business scope includes: sales of machinery and equipment; Sales of coal and products; Sales of renewable resources; Import and export agents, etc. Enterprise equity penetration shows that the company is jointly held by ST Mo Long and others.Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.Jinshanyun's information technology company increased its capital to USD 500 million. Tianyancha App shows that Jinshan Yun (Hainan Yangpu) Information Technology Co., Ltd. has undergone industrial and commercial changes recently, and its registered capital has increased from USD 400 million to USD 500 million. The company was established in August 2022, and its legal representative is Zou Tao. Its business scope is Internet domain name registration service, computer software and hardware and auxiliary equipment wholesale, technical service, technical development, technical consultation, technical exchange, technology transfer, technology promotion, information system integration service, software development and software sales, and it is wholly owned by Jinshanyun Co., Ltd.